Shuji Matsuoka
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
IL-26-driven epigenetic remodeling promotes immune evasion in colorectal cancer.
Journal: Nature communications
Published: January 29, 2026
Cytokeratin Detection in Lymphoid Tumor Cell Lines: Implications for Flow Cytometry and Molecular Analyses.
Journal: Cell biology international
Published: January 26, 2026
"Biophysical and colloidal properties govern anti-drug antibody generation: A case study using the tumoricidal murine-derived monoclonal antibody 4713".
Journal: International journal of biological macromolecules
Published: September 04, 2025
Excessive IL-4 environment enhances osteoclastogenesis and modulates inflammatory cell differentiation in bone loss associated with food allergic enteropathy.
Journal: Allergology international : official journal of the Japanese Society of Allergology
Published: May 06, 2025
Novel anti-ITGA4 monoclonal antibody induces cell death via large pore formation in NK/T-cell lymphoma cells.
Journal: Scientific reports
Published: February 13, 2025
A New CD10 Antibody Inhibits the Growth of Malignant Mesothelioma.
Journal: Monoclonal antibodies in immunodiagnosis and immunotherapy
Published: February 24, 2021
Effector memory CD4+T cells in mesenteric lymph nodes mediate bone loss in food-allergic enteropathy model mice, creating IL-4 dominance.
Journal: Mucosal immunology
Published: August 06, 2020
Vasculitis and crescentic glomerulonephritis in a newly established congenic mouse strain derived from ANCA-associated vasculitis-prone SCG/Kj mice.
Journal: Autoimmunity
Published: September 04, 2019
Development of novel monoclonal antibodies with specific binding affinity for denatured human CD26 in formalin-fixed paraffin-embedded and decalcified specimens.
Journal: PloS one
Published: March 08, 2019
Biological Effects of IL-26 on T Cell-Mediated Skin Inflammation, Including Psoriasis.
Journal: The Journal of investigative dermatology
Published: June 19, 2018
Establishment of a Therapeutic Anti-Pan HLA-Class II Monoclonal Antibody That Directly Induces Lymphoma Cell Death via Large Pore Formation.
Journal: PloS one
Published: September 11, 2015
Last Updated: 09/26/2026